Sage Journals: Discover world-class research

Free access

Research article

First published 2021

Evaluation of doravirine-based regimen population target in a large Italian clinical center

Damiano Farinacci, Arturo Ciccullo, Francesca Lombardi [...]

Antiviral Therapy

Free access

Research article

First published 2017-5

Effect of Gender and Age on the Relative Bioavailability of Doravirine: Results of a Phase I Trial in Healthy Subjects

Martin O Behm, Ka L Yee, Li Fan [...]

Antiviral Therapy

Free access

Research article

First published 2021

Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients

Kaja Scheibe, Anna Urbańska, Paweł Jakubowski [...]

Antiviral Therapy

Retricted access

Review article

First published 2020-1

Doravirine: A Return of the NNRTI Class?

Sarah R. Blevins, E. Kelly Hester, Daniel B. Chastain [...]

Annals of Pharmacotherapy

Retricted access

Case report

First published 2022-6

Doravirine/tenofovir disoproxyl fumarate/lamivudine-induced alopecia: A case report

Dario Cattaneo, Agostino Riva, Andrea Poloni [...]

International Journal of STD & AIDS

Retricted access

Research article

First published 2022-10

HIV treatment with dolutegravir and doravirine: rationale for selection and clinical outcomes in a highly treatment experienced population

Rachel Denyer, Julie Zemskova, Debra A Benator

International Journal of STD & AIDS

Retricted access

Research article

First published 2024-3

Real world utilisation of doravirine among people living with human immunodeficiency virus in England (DRIVE-REAL)

Charlotte O’Halloran, Yvonne Gilleece, Suki Leung [...]

International Journal of STD & AIDS

Free access

Research article

First published 2015-5

Safety,Tolerability and Pharmacokinetics of Doravirine,a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor,after Single and Multiple doses in Healthy Subjects

Matt S Anderson, Jocelyn Gilmartin, Caroline Cilissen [...]

Antiviral Therapy

Free access

Research article

First published 2019-8

Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial

Jose M Gatell, Javier O Morales-Ramirez, Debbie P Hagins [...]

Antiviral Therapy

Retricted access

Research article

First published 2023-12

Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience

Leonardo Calza, Vincenzo Colangeli, Giulia Pensalfine [...]

International Journal of STD & AIDS

Search results